Development of Opioid and Adjuvant Fixed Combination Dosage Forms for the Treatment of Chronic Pain with Reduced Addiction Potential (R43/R44)

Funding Opportunity Number: PA-13-387 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.279Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Jan 07, 2017Award Ceiling: Expected Number of Awards: Creation Date: Nov 07, 2013Funding Opportunity Description: The purpose of this announcement is to fund meritorious applications from small business organizations that aim to develop of opioid and adjuvant drug combinations within a single dosage form for treatment of a pain condition. The drug combination should provide improved analgesia when compared with the same dose (morphine equivalents) of opioid monotherapy. Such dosage forms should minimize opioid exposure while optimizing analgesia, in order to reduce risk of addiction and limit severity of other opiate adverse effects.
Source: Grants.gov - Category: Research Tags: Education Health Source Type: funding